Health ❯ Chronic Diseases ❯ Diabetes ❯ Type 2 Diabetes

GLP-1 Treatments

FDA Creates 'Green List' for GLP-1 Ingredients as WHO Names the Drugs Essential

The move targets unsafe compounded supplies after shortages pushed patients toward unapproved versions.

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research